T. Mino et al. / Tetrahedron: Asymmetry 19 (2008) 2711–2716
2715
1H), 4.27 (dd, J = 8.5 and 10.9 Hz, 1H), 6.33 (dd, J = 8.5 and 15.8 Hz,
4.4. Determination of absolute configuration of 2b
4.4.1. Resolution of 1,3-diphenyl-2-propene-1-ol
The resolution was carried out by the use of a chiral stationary
phase column [Chiralcel OD-H (1.0 / ꢂ 25 cm), flow rate = 0.5 mL/
min, hexane/iPrOH = 95:5] to give both enantiomers. A 0.25 mL of
solution was injected for each batch using 110 mg of ( )-1,3-diphe-
nyl-2-propene-1-ol in EtOH (4.25 mL). Enantiomers were eluted at
38 min for (S)-isomer and 48 min for (R)-isomer.14
1H), 6.48 (d, J = 15.8 Hz, 1H), 7.17–7.34 (m, 10H); 13C NMR
(75 MHz, CDCl3) d 49.2, 52.4, 52.6, 57.6, 126.4, 127.1, 127.5,
127.8, 128.5, 128.7, 129.1, 131.8, 136.8, 140.1, 167.8, 168.2; EI-
MS m/z (rel intensity) 324 (M+, 13).
4.3. General procedure for the kinetic resolution of various
allylic esters 2 in palladium-catalyzed allylic alkylation (Table 3)
To a mixture of [Pd(g
3-C3H5)Cl]2 (0.01 mmol, 3.9 mg), chiral
aminophosphine ligand (S)-1c (0.02 mmol, 9.0 mg), and LiOAc
(0.004 mmol, 0.3 mg) in PhMe (0.7 mL) was added racemic allylic
ester 2 (0.2 mmol) at room temperature under an Ar atmosphere.
After 30 min, BSA (0.6 mmol, 0.15 mL) and malonate (0.12 mmol)
in PhMe (1.2 M, 0.1 mL) were added at 25 °C. After 18 h, the reac-
tion mixture was diluted with diethyl ether and water. The organic
layer was washed with brine and dried over MgSO4. The filtrate
was concentrated with a rotary evaporator and the reaction con-
version was determined by 1H NMR. The residue was purified by
4.4.2. (S)-1,3-Diphenyl-2-propene-1-ol
38 mg, 68%; >99% ee; ½a D20
¼ ꢀ31:9 (c 0.29, CHCl3); HPLC (Daicel
ꢁ
CHIRALCELÒ OD-H, 0.46 / ꢂ 25 cm, flow rate = 0.5 mL/min, hex-
ane/iPrOH = 90:10, detection at 254 nm) tR = 33.1 min; 1H NMR
(300 MHz, CDCl3) d 2.03 (s, br, 1H), 5.40 (d, J = 4.6 Hz, 1H), 6.39
(dd, J = 6.5 and 15.8 Hz, 1H), 6.70 (d, J = 15.8 Hz, 1H), 7.21–7.46
(m, 10H); 13C NMR (75 MHz, CDCl3) d 75.1, 126.3, 126.6, 127.8,
127.8, 128.6, 128.6, 130.6, 131.5, 136.5, 142.7; EI-MS m/z (rel
intensity) 210 (M+, 34).
column
chromatography
(hexane/ethyl
acetate/triethyl-
amine = 34:1:6) to give (R)-2 and (R)-3.
4.4.3. (R)-1,3-Diphenyl-2-propene-1-ol
38 mg, 68%; >99% ee; ½a D20
¼ þ34:8 (c 0.30, CHCl3); HPLC (Daicel
ꢁ
4.3.1. Compound (R)-2b11
CHIRALCELÒ OD-H, 0.46 / ꢂ 25 cm, flow rate = 0.5 mL/min, hex-
ane/iPrOH = 90:10, detection at 254 nm) tR = 43.0 min; 1H NMR
(300 MHz, CDCl3) d 2.03 (s, br, 1H), 5.40 (d, J = 4.6 Hz, 1H), 6.39
(dd, J = 6.5 and 15.8 Hz, 1H), 6.70 (d, J = 15.8 Hz, 1H), 7.24–7.46
(m, 10H); 13C NMR (75 MHz, CDCl3) d 75.1, 126.3, 126.6, 127.8,
127.8, 128.6, 128.6, 130.6, 131.5, 136.5, 142.7; EI-MS m/z (rel
intensity) 210 (M+, 30).
(Table 3, entry 2) 29 mg, 0.10 mmol, 49% yield; 55% ee (Daicel
CHIRALPAKÒ AS-H, flow rate = 0.25 mL/min, hexane/iPrOH = 99:1,
detection at 254 nm: tR 17.0 min ((R)-2b), tR 18.8 min ((S)-2b));
½
a 2D0
ꢁ
¼ þ3:4 (c 0.35, CHCl3); 1H NMR (300 MHz, CDCl3) d 1.25 (s,
9H), 6.32 (dd, J = 6.8 and 15.6 Hz, 1H), 6.41 (d, J = 6.9 Hz, 1H),
6.63 (d, J = 15.6 Hz, 1H), 7.23–7.41 (m, 10H); 13C NMR (75 MHz,
CDCl3) d 27.1, 38.9, 75.7, 126.67, 126.72, 127.8, 127.9, 128.0,
128.5, 128.5, 132.2, 136.3, 139.6, 177.3; EI-MS m/z (rel intensity)
294 (M+, 4).
4.4.4. Preparation of (R)-2b
To a mixture of (R)-1,3-diphenyl-2-propene-1-ol (0.179 mmol,
38 mg), triethylamine (0.9 mL), and DMAP (0.04 mmol, 4 mg) was
4.3.2. Compound (R)-3a
added pivaloyl chloride (0.179 mmol, 23 lL) at room temperature.
(Table 3, entry 2) 28 mg, 0.09 mmol, 43% yield; 94% ee.
After 21 h, the reaction mixture was diluted with 2 M HCl aq and
diethyl ether. The organic layer was washed with water, brine,
and dried over MgSO4. The filtrate was concentrated with a rotary
evaporator and the residue was purified by column chromatogra-
phy (hexane/ethyl acetate = 100:1) to give (R)-2b (16 mg,
0.054 mmol).
4.3.3. Compound (R)-2c10a,12
(Table 3, entry 3) 26 mg, 0.08 mmol, 42% yield; 59% ee (Daicel
CHIRALCELÒ OD-H + OD-H, flow rate = 0.30 mL/min, hex-
ane/iPrOH = 99:1, detection at 254 nm: tR 49.1 min (CD: kext
(De)
254 (ꢀ)) ((S)-2c), tR 55.0 min (CD: kext
(De) 254 (+)) ((R)-2c));
½
a 2D0
ꢁ
¼ þ8:0 (c 0.30, CHCl3); 1H NMR (300 MHz, CDCl3) d 6.47 (dd,
4.4.5. Compound (R)-2b
30% yield; 97% ee (Daicel CHIRALPAKÒ AS-H, flow rate = 0.25 mL/
min, hexane/iPrOH = 99:1, detection at 254 nm): tR 20.2 min (major,
J = 6.8 and 15.9 Hz, 1H), 6.69–6.76 (m, 2H), 7.21–7.59 (m, 13H),
8.13 (d, J = 8.3 Hz, 2H); 13C NMR (75 MHz, CDCl3) d 76.6, 126.7,
127.0, 127.5, 128.0, 128.2, 128.4, 128.6, 128.6, 129.7, 130.3,
132.8, 133.1, 136.1, 139.3, 165.6; EI-MS m/z (rel intensity) 314
(M+, 3).
(R)-2b), tR 23.0 min (minor, (S)-2b)); ½a D20
ꢁ
¼ þ4:1 (c 0.30, CHCl3); 1H
NMR (300 MHz, CDCl3) d 1.25 (s, 9H), 6.32 (dd, J = 6.7 and 15.6 Hz,
1H), 6.41 (d, J = 7.0 Hz, 1H), 6.63 (d, J = 15.5 Hz, 1H), 7.24–7.41 (m,
10H); 13C NMR (75 MHz, CDCl3) d 27.1, 38.9, 75.7, 126.67, 126.72,
127.8, 127.9, 128.0, 128.5, 128.5, 132.2, 136.3, 139.6, 177.3; EI-MS
m/z (rel intensity) 294 (M+, 4).
4.3.4. Compound (R)-3a
(Table 3, entry 3) 35 mg, 0.11 mmol, 55% yield; 94% ee.
4.3.5. Compound (R)-2a
References
(Table 3, entry 4) 22 mg, 0.09 mmol, 43% yield; 78% ee.
1. For reviews, see the following: (a) Trost, B. M.; Crawley, M. L. Chem. Rev. 2003,
103, 2921; (b) Trost, B. M. Chem. Pharm. Bull. 2002, 50, 1; (c) Trost, B. M.; Lee, C.
In Catalytic Asymmetric Synthesis; Ojima, I., Ed., 2nd ed.; VCH: New York, 2000;
p 893; (d) Williams, J. M. J. Synlett 1996, 705; (e) Pfaltz, A.; Lautens, M. In
Comprehensive Asymmetric Catalysis; Jacobsen, E. N., Pfaltz, A., Yamamoto, H.,
Eds.; Springer: New York, 1999. Chapter 24; (f) Trost, B. M.; Van Vranken, D. L.
Chem. Rev. 1996, 96, 395; (g) Pfaltz, A. Acc. Chem. Res. 1993, 26, 339; (h)
Hayashi, T. In Catalytic Asymmetric Synthesis; Ojima, I., Ed.; VCH: New York,
1993; p 325; (i) Consiglio, G.; Waymouth, R. M. Chem. Rev. 1989, 89, 275.
2. Helmchen, G.; Pfaltz, A. Acc. Chem. Res. 2000, 33, 336.
3. (a) Guiry, P. J.; Saunders, C. P. Adv. Synth. Catal. 2004, 346, 497; (b) Pfaltz, A.;
Drury, W. J. Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 5723; (c) Togni, A.; Burckhardt,
U.; Gramlich, V.; Pregosin, P. S.; Salzmann, R. J. Am. Chem. Soc. 1996, 118, 1031.
4. (a) Matt, P. v.; Pfaltz, A. Angew. Chem., Int. Ed. 1993, 32, 566; (b) Matt, P. v.;
Loiseleur, O.; Koch, G.; Pfaltz, A.; Lefeber, C.; Feucht, T.; Helmchen, G.
Tetrahedron: Asymmetry 1994, 5, 573; (c) Matt, P. V.; Lloyd-Jones, G. C.;
4.3.6. Compound (R)-3b8c
(Table 3, entry 4) 35 mg, 0.10 mmol, 49% yield; 94% ee (Daicel
CHIRALCELÒ OJ, flow rate = 0.7 mL/min, hexane/iPrOH = 95:5,
detection at 254 nm: tR 13.6 min ((R)-3b), tR 16.0 min ((S)-3b));
½
a 2D0
ꢁ
¼ þ16:8 (c 0.31, CHCl3); 1H NMR (300 MHz, CDCl3) d 1.00
(t, J = 7.1 Hz, 3H), 1.20 (t, J = 7.1 Hz, 3H), 3.90–4.00 (m, 3H),
4.17 (q, J = 7.1 Hz, 2H), 4.26 (dd, J = 8.4 and 10.9 Hz, 1H), 6.33
(dd, J = 8.4 and 15.7 Hz, 1H), 6.48 (d, J = 15.8 Hz, 1H), 7.16–7.33
(m, 10H); 13C NMR (75 MHz, CDCl3) d 13.7, 14.1, 49.2, 57.7,
61.3, 61.5, 126.3, 127.1, 127.5, 128.0, 128.4, 128.6, 129.3,
131.6, 136.8, 152.2, 167.4, 167.8; EI-MS m/z (rel intensity) 352
(M+, 15).